These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3581713)
21. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797 [TBL] [Abstract][Full Text] [Related]
22. Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients. Niho Y; Till JE; McCulloch EA Exp Hematol; 1976 Mar; 4(2):63-9. PubMed ID: 1063075 [TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960 [TBL] [Abstract][Full Text] [Related]
24. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen. Cen D; Levin J Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543 [TBL] [Abstract][Full Text] [Related]
25. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells. Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470 [TBL] [Abstract][Full Text] [Related]
26. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C. Ben-Ishay Z; Borenstein A; Sharon S; Prindull G Int J Cell Cloning; 1983 Oct; 1(5):343-59. PubMed ID: 6672102 [TBL] [Abstract][Full Text] [Related]
27. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells]. He Q; Xu YH Yao Xue Xue Bao; 1996; 31(5):340-5. PubMed ID: 9275711 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes. Swolin B; Rödjer S; Westin J Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412 [TBL] [Abstract][Full Text] [Related]
29. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375 [TBL] [Abstract][Full Text] [Related]
30. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
31. Bone marrow cultures and prognosis in primary myelodysplastic syndromes. Korthout M; De Bock R; van Bockstaele D; Peetermans M Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates. Gallicchio VS; Casale GP; Watts T Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410 [TBL] [Abstract][Full Text] [Related]
33. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes]. Zhang F; Hao Y; Pang W Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678 [TBL] [Abstract][Full Text] [Related]
34. Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and alpha-interferon on bone marrow cells from patients with myelodysplastic syndromes. Hellström E; Robèrt KH; Soppi E; Ost A; Putkonen PO; Gahrton G Leuk Res; 1989; 13(12):1113-21. PubMed ID: 2615468 [TBL] [Abstract][Full Text] [Related]
35. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors. Merchav S; Wagemaker G; Souza LM; Tatarsky I Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes. Juvonen E; Aimolahti A; Volin L; Ruutu T Leuk Res; 1999 Oct; 23(10):889-94. PubMed ID: 10573133 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders. Yuo A; Miyazono K; Urabe A; Takaku F Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895 [TBL] [Abstract][Full Text] [Related]
38. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248 [TBL] [Abstract][Full Text] [Related]
39. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R. Li B; Liu J; Qu S; Gale RP; Song Z; Xing R; Liu J; Ren Y; Xu Z; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Hu N; Cai W; Zhang P; Huang G; Xiao Z Oncotarget; 2016 Oct; 7(42):68023-68032. PubMed ID: 27655727 [TBL] [Abstract][Full Text] [Related]
40. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients. Gidáli J; Fehér I; Hollán SR Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]